Bal Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 28, 2014, inter alia, for transacting the following business:<br/><br/>1. Consideration of the Audited Financial Results of the Company for the IVth quarter and financial year ended March 31, 2014.<br/><br/>2. Appropriation of profits including recommendation of Dividend, if any.<br/><br/>3. Consideration of various subjects relating to Annual General Meeting <br/><br/>4. Book closure and Convening of A G M.
|